Karolinska Institutet | Emelie Foord explains new findings about the role of certain T cells in ovarian cancer @karolinskainstitutet | Uploaded 3 years ago | Updated 5 hours ago
A study from Karolinska Institutet published in Science Translational Medicine (January 2021) shows that a subset of immune cells called gamma delta T cells are associated with increased survival in patients with advanced ovarian cancer. PhD student Emelie Foord in Michael Uhlin's research group explains the results and potential clinical implications.
A study from Karolinska Institutet published in Science Translational Medicine (January 2021) shows that a subset of immune cells called gamma delta T cells are associated with increased survival in patients with advanced ovarian cancer. PhD student Emelie Foord in Michael Uhlin's research group explains the results and potential clinical implications.